EUTM file information

004102687

TREANDA


October 25, 2004

Trademark Summary

The trademark application TREANDA was filed by Cephalon, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 10, 2005, and it was registered by office on February 2, 2006 without any oppositions.

The application was filed in English (Spanish was selected as the second language).

Cancellation Proceedings

A total of undefined cancellation proceedings were initiated against the trademark registration in 2006.The first Cancellation was filed by Mundipharma AG (represented by ELKINGTON AND FIFE LLP) on November 6, 2012 and Final decision – EUTM fully cancelled.

Change of name and address of the trademark registration was recorded on May 30, 2005. Change of name and professional address of the trademark registration was recorded on March 24, 2006. Change of name and professional address of the trademark registration was recorded on November 23, 2006. A transfer of the trademark registration was recorded on July 22, 2007. Change of name and professional address of the trademark registration was recorded on August 19, 2007. Application for revocation or for a declaration of invalidity of the trademark registration was recorded on September 28, 2011. Decisions on applications for revocation or for a declaration of invalidity of the trademark registration was recorded on November 14, 2012.

The Cancellation with reference B 000005830 was EUTM cancelled according to Article 51(1)(a) CTMR with decision issued on June 17, 2012 by the EUIPO.


Goods And Services

  • The mark was filed in class 1 with Chemicals used in industry and science.
  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations, compounds and products
    2. Drugs for medical purposes
    3. Pharmaceutical preparations for the treatment of cancer
    4. Diagnostic agents for in vivo use to locate cancer
    5. Immunotherapeutic agents for cancer.
  • The mark was filed in class 44 with following description of goods:
    1. Advisory services relating to pharmaceutical preparations, compounds and products
    2. Advisory services relating to pharmaceutical preparations, compounds and products for the treatment of cancer
    3. Collection of information relating to the use of pharmaceuticals
    4. Professional consultancy relating to pharmaceutical products
    5. Provision of pharmaceutical information
    6. Consultancy, information and advisory services relating to the aforesaid.